2023年至2028年電子處方箋市場預測
市場調查報告書
商品編碼
1410025

2023年至2028年電子處方箋市場預測

E-Prescribing Market - Forecasts from 2023 to 2028

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計電子處方箋市場在預測期內將以 17.49% 的複合年成長率成長。

電子處方箋市場的成長正在迅速擴大,並且預計很快就會發生。先進醫療服務創新的廣泛使用、政府估計對電子健康記錄(EHR) 的支持以及對解決藥物安全和患者治療結果的渴望正在推動這一發展。電子處方箋市場規模受到醫療機構對電子處方箋系統和解決方案的需求的影響。市場參與企業的電子處方箋市場佔有率龐大,這增加了電子推薦市場的競爭力和活力。隨著醫療保健產業擁抱數位轉型,電子處方箋市場的成長有望持續成長和創新。

介紹

由於先進醫療服務解決方案的使用越來越多,電子處方箋市場規模正在經歷重大轉折和變化。電子處方箋是在醫療服務專業人員和藥局之間以電子方式傳輸和交付治療藥物訂單的系統。電子處方箋消除了對傳統紙本解決方案的需求,並具有提高用藥準確性、提高病患安全性和加快工作速度等優點。

隨著醫療保健服務協會和供應商意識到從紙本解決方案轉向電子框架的好處,電子處方箋市場迅速成長。電子處方箋預計將在醫療服務數位化中發揮基礎性作用,並有可能提高醫療保健理解、減少治療錯誤並提高醫療保健熟練程度。

電子處方箋市場的主要企業

  • Epic Systems Corporation: Epic 是著名的 EHR 框架提供者,其電子處方箋模組允許醫療專業人員以電子方式向藥局提交藥物。該模組旨在與其他令人驚嘆的 EHR 元素結合使用,為管理人員提供高效的藥物和準確的支援。
  • DrFirst Inc: DrFirst 是電子建議和安全通訊管理領域的重要權威。該公司的 Rcopia 創新提供電子處方、藥物歷史管理和藥物妥協設備,幫助醫療保健專業人員駕馭治療週期並了解安全性。
  • Surescripts管理全國最大的醫療資訊組織。除了提供電子處方箋外,我們還建立了一個全國性組織,作為醫療專業人員和藥局之間的介面,允許電子處方箋的移動和藥物歷史的訪問。
  • Cerner Corporation Cerner Organization 是健康服務資料創新領域的市場領導者。該公司提供電子健康記錄(EHR) 框架和相關的電子處方處方箋,使衛生服務臨床醫生能夠以電子方式提供和提交治療、訪問用藥歷史和升級藥物。

市場促進因素:

市場促進因素:電子病歷採用率的提高和醫療數位化舉措:

普及醫療保健數位化措施和電子健康記錄(EHR) 的日益普及,對電子處方箋方案的需求不斷增加。這項需求是由提高病患安全、簡化業務流程和進一步提高經營團隊效率的願望所推動的。

進一步提升電子處方箋的成本和有效性優勢:

電子處方箋框架透過消除文書工作、減少藥物失敗和加快治療週期來釋放現金和時間。這使得醫療保健提供者能夠利用電子處方箋的進步來改善患者的治療結果並增強業務。

科技的發展:

多功能應用程式和雲端基礎的平台等醫療保健創新的推動將推動電子處方箋市場向前發展。這些創新可以與現有的衛生服務框架保持一致的聯繫,進一步發展開放性,並為衛生服務專業人員和患者提供持續的解決方案資料。

預計電子處方箋市場將在預測期內穩定成長。

電子處方箋市場按產品、交付型態、最終用戶和地區進行細分。產品進一步細分為服務和解決方案。交付型態進一步分為本地、雲端基礎和基於網路。

北美預計將引領全球電子處方箋市場。

北美是電子處方箋市場的領導者,在電子處方箋市場中佔有重要佔有率。該地區的主導地位有幾個原因。首先,成熟的醫療保健基礎設施和現代醫療保健 IT 系統正在推動電子處方箋解決方案的普及。其次,鼓勵使用電子健康記錄(EHR)和數位處方箋的政府舉措和法律正在刺激產業擴張。此外,醫療保健專業人員和患者對電子處方箋益處的廣泛認可也促進了處方箋在北美的廣泛接受。由於該領域的主要競爭對手和聯盟/合作夥伴關係,北美在電子處方箋市場的市場地位正在提高。

主要進展:

2023 年 6 月,Telecare 宣布推出澳洲首個獨立電子處方箋平台 RxPad。雲端基礎的平台允許醫療保健專業人員編寫處方箋,而無需將其輸入實踐管理軟體,從而進一步改善了查看和編輯患者處方箋。 2023 年 1 月標誌著 Pharmacy Data 的推出,這是互通性平台和健康資訊網路 (HIN) 公司 Health Gorilla 推出的新解決方案,可讓大多數主要藥房輕鬆存取全面的處方歷史資料。 DrFirst 的 MedHx 人口風險管理 (PRM) 系統為藥房資料提供支持,提供來自區域和國家資料來源的重複處方歷史記錄,例如處方資料、藥房配藥資料和藥房福利管理申請。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表

第2章調查方法

  • 調查資料
  • 先決條件

第3章執行摘要

  • 研究亮點

第4章市場動態

  • 市場促進因素
  • 市場抑制因素
  • 波特五力分析
  • 產業價值鏈分析

第5章電子處方箋市場:分產品

  • 介紹
  • 解決方案
  • 服務

第6章 電子處方箋市場:依交付模式

  • 介紹
  • 基於網路的
  • 本地
  • 雲端基礎

第 7 章 電子處方箋市場:依最終使用者分類

  • 介紹
  • 醫院
  • 醫生檢查室
  • 藥局

第8章電子處方箋市場:按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印尼
    • 台灣
    • 其他

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作

第10章 公司簡介

  • Cerner Corporation
  • Veradigm LLC(Formerly AllScripts)
  • athenahealth
  • NextGen Healthcare, Inc.
  • McKesson Corporation
  • Practice Fusion, Inc.(acquired by Veradigm LLC)
  • Surescripts LLC
  • DrFirst
  • Medical Information Technology, Inc.(MEDITECH)
簡介目錄
Product Code: KSI061615677

The E-Prescribing market is estimated to grow at a CAGR of 17.49% during the forecast period.

The E-Prescribing market growth is expanding quickly and is supposed to do so sooner rather than later. The expanded use of advanced medical services innovations, government estimates supporting electronic health records (EHRs), and the craving to work on drug security and patient results are driving this development. The E-Prescribing market size is influenced by healthcare organizations' requirements for E-Prescribing systems and solutions. The market's significant participants have huge E-Prescribing market shares, which adds to the general competitiveness and dynamism of the E-Recommending market. As the healthcare sector embraces digital transformation, the e-prescription market growth is poised for ongoing growth and innovation.

Introduction:

Due to the expanded utilization of advanced medical services solutions, the E-Prescribing market size is seeing a significant turn of events and change. The course of electronically delivering and conveying remedy orders between medical services professionals and drug stores is known as e-prescribing. It takes out the requirement for customary paper-based solutions, bringing about a few benefits like expanded drug precision, more noteworthy patient security, and quicker tasks.

The E-Prescribing market growth is growing quickly as medical services associations and suppliers see the advantages of moving from paper-based solutions to electronic frameworks. E-prescribing is ready to assume a basic part in the computerized unrest of medical services, with the possibility to work on understanding healthcare, limit remedy slip-ups, and increment by and large healthcare proficiency.

Key Players in the E-Prescribing Market:

  • Epic Systems Corporation: Epic is a notable EHR framework provider, and its E-Prescribing module empowers medical care specialists to submit remedies to drug stores electronically. The module is intended to work couple with other Awe-inspiring EHR elements to give productive medication to the executives and exact endorsing.
  • DrFirst Inc.: DrFirst represents considerable authority in electronic recommending and secure correspondence administration. Their Rcopia innovation gives electronic prescribing, medicine history administrations, and drug compromise devices, helping medical care specialists advance the remedy cycle and work on understanding security.
  • Surescripts: Surescripts deals with the country's biggest health information organization. They give E-Prescribing administrations, as well as a countrywide organization that interfaces medical care professionals and drug stores, considering electronic prescription moves and medicine history access.
  • Cerner Corporation: Cerner Organization is a market chief in medical services data innovation. They give E-Prescribing arrangements that are associated with their electronic health records (EHR) frameworks, permitting medical services clinicians to deliver and submit remedies electronically, access medicine chronicles, and upgrade drug the board.

MARKET DRIVERS:

Increasing Adoption of EHRs and healthcare digitalization initiatives to boost the market:

E-prescribing solutions are in high demand as healthcare digitalization initiatives and electronic health records (EHRs) gain traction. The longing to increase patient security, smooth out work processes, and further develop drug the executive's productivity is driving this reception.

Cost and effectiveness benefits to further fuel the e-prescribing:

E-prescribing frameworks set aside cash and time by disposing of desk work, decreasing drug botches, and speeding up the remedy cycle. This spurs medical care suppliers to send E-Prescribing advances to improve patient results and upgrade their tasks.

Technological Advancements:

Propels in healthcare innovation, including versatile applications and cloud-based stages, help to drive the E-Prescribing market forward. These innovations take into consideration consistent association with existing medical services frameworks, further developed openness, and constant solution data for both medical services experts and patients.

The e-prescribing market is anticipated to grow at a steady rate in the forecast period.

The market for e-prescribing is segmented by product, delivery mode, end-user, and geography. The product is further segmented into services and solutions. Delivery mode is further segmented into on-premises, cloud-based, and web-based.

North America is expected to be a leading e-prescribing marketplace globally.

North America is the market leader in E-Prescribing, with a significant e-prescribing market share. Several reasons contribute to the region's prominence. For starters, the availability of established healthcare infrastructure and modern healthcare IT systems has aided E-Prescribing solution uptake. Second, government initiatives and legislation encouraging the use of electronic health records (EHRs) and digital prescriptions have spurred industry expansion. Furthermore, a great awareness of the benefits of E-Prescribing among healthcare practitioners and patients has helped to its broad acceptance in North America. Major competitors in the area, as well as alliances and partnerships, have enhanced North America's market position in the E-Prescribing market.

Key Developments:

  • In June 2023, Telecare launched Australia's first stand-alone e-prescription platform namely "RxPad" which is compliant with Australian Digital Health Agency guidelines. The cloud-based platform enables medical professionals to write off prescriptions without entering into any practice management software and further increases their access to view and edit patient's prescriptions.
  • In January 2023, Pharmacy Data is a new solution from Health Gorilla, a leading interoperability platform and Health Information Network (HIN), that makes it simple to access comprehensive prescription history data from most major pharmacies. DrFirst's MedHx Population Risk Management (PRM) system is the driving force behind Pharmacy Data, which delivers deduplicated prescription history from local and national data sources like prescribing data, pharmacy dispensing data, and pharmacy benefits management claims.

Segmentation

BY PRODUCT

  • Solutions
  • Services

BY DELIVERY MODE

  • Web-based
  • On-premise
  • Cloud-based

BY END-USER

  • Hospitals
  • Physician Offices
  • Pharmacies

BY Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. E-PRESCRIBING MARKET, BY PRODUCT

  • 5.1. Introduction
  • 5.2. Solutions
  • 5.3. Services

6. E-PRESCRIBING MARKET, BY DELIVERY MODE

  • 6.1. Introduction
  • 6.2. Web-based
  • 6.3. On-premises
  • 6.4. Cloud-based

7. E-PRESCRIBING MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Physician Offices
  • 7.4. Pharmacies

8. E-PRESCRIBING MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. United States
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. The Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Taiwan
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

  • 10.1. Cerner Corporation
  • 10.2. Veradigm LLC (Formerly AllScripts)
  • 10.3. athenahealth
  • 10.4. NextGen Healthcare, Inc.
  • 10.5. McKesson Corporation
  • 10.6. Practice Fusion, Inc. (acquired by Veradigm LLC)
  • 10.7. Surescripts LLC
  • 10.8. DrFirst
  • 10.9. Medical Information Technology, Inc. (MEDITECH)